Neuroendocrine differentiation of prostate cancer leads to PSMA suppression.

Saved in:
Bibliographic Details
Title: Neuroendocrine differentiation of prostate cancer leads to PSMA suppression.
Authors: Bakht MK; Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea.; Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.; Department of Biological Sciences, University of Windsor, Windsor, Ontario, Canada., Derecichei I; Department of Biological Sciences, University of Windsor, Windsor, Ontario, Canada., Li Y; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Ferraiuolo RM; Department of Biological Sciences, University of Windsor, Windsor, Ontario, Canada., Dunning M; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Oh SW; Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea., Hussein A; Department of Mathematics and Statistics, University of Windsor, Windsor, Ontario, Canada., Youn H; Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea.; Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.; Tumor Microenvironment Global Core Research Center, Seoul National University, Seoul, Korea.; Cancer Imaging Center, Seoul National University Hospital, Seoul, Korea., Stringer KF; Department of Biological Sciences, University of Windsor, Windsor, Ontario, Canada.; Department of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Jeong CW; Department of Urology, Seoul National University College of Medicine, Seoul, Korea., Cheon GJ; Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea.; Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea., Kwak C; Department of Urology, Seoul National University College of Medicine, Seoul, Korea., Kang KW; Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea.; Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea., Lamb AD; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Wang Y; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Experimental Therapeutics, BC Cancer Research Centre, Vancouver, British Columbia, Canada., Dong X; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Porter LA; Department of Biological Sciences, University of Windsor, Windsor, Ontario, Canada.
Source: Endocrine-related cancer [Endocr Relat Cancer] 2018 Nov 23; Vol. 26 (2), pp. 131-146. Date of Electronic Publication: 2018 Nov 23.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioScientifica Country of Publication: England NLM ID: 9436481 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-6821 (Electronic) Linking ISSN: 13510088 NLM ISO Abbreviation: Endocr Relat Cancer
Database: MEDLINE Ultimate
Description
ISSN:1479-6821
DOI:10.1530/ERC-18-0226